1. Home
  2. BBGI vs RVPH Comparison

BBGI vs RVPH Comparison

Compare BBGI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

SELL

Current Price

$21.51

Market Cap

10.5M

ML Signal

SELL

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.85

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBGI
RVPH
Founded
1961
2006
Country
United States
United States
Employees
N/A
14
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
9.2M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
BBGI
RVPH
Price
$21.51
$0.85
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$72.00
AVG Volume (30 Days)
2.2M
1.1M
Earning Date
04-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$232,179,463.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
69.89
N/A
52 Week Low
$3.14
$0.17
52 Week High
$26.37
$3.11

Technical Indicators

Market Signals
Indicator
BBGI
RVPH
Relative Strength Index (RSI) 86.23 48.19
Support Level $3.93 $0.44
Resistance Level $26.37 $0.99
Average True Range (ATR) 2.95 0.12
MACD 1.60 -0.00
Stochastic Oscillator 89.20 67.35

Price Performance

Historical Comparison
BBGI
RVPH

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: